Forskningsartikel2024Vetenskapligt granskad
Clinical significance of the TK1 specific activity in the early detection of ovarian cancer
Osredkar, Josko; Jagarlamudi, Kiran Kumar; Cviic, Diana et al.
Kiran Kumar Jagarlamudi
Institutionen för husdjurens biovetenskaper
Fakulteten för veterinärmedicin och husdjursvetenskap
E-post: kirankumar.j@slu.se
ORCID: 0000-0003-1567-5863
Publikationer
Forskningsartikel2022Vetenskapligt granskadÖppen tillgång
Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies
Saellstrom, S.; Sharif, H.; Jagarlamudi, K. K. et al.
Forskningsartikel2022Vetenskapligt granskadÖppen tillgång
Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer
Lundgren, Per-Olof; Tribukait, Bernhard; Kjellman, Anders et al.
Forskningsartikel2019Vetenskapligt granskad
The combination of AroCell TK 210 ELISA with Prostate Health Index or prostate-specific antigen density can improve the ability to differentiate prostate cancer from noncancerous conditions
Jagarlamudi, Kiran Kumar; Zupan, Mojca; Kumer, Kristina et al.
Översiktsartikel2018Vetenskapligt granskadÖppen tillgång
Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker
Jagarlamudi, Kiran Kumar; Shaw, Martin.
Forskningsartikel2018Vetenskapligt granskad
Doxorubicin effects on leukemia and breast cancer cells in culture on the TK1 protein levels using AroCell TK 210 ELISA: a tool for drug development
Jagarlamudi, K. K.; Wang, L.; Eriksson, S..
Forskningsartikel2016Vetenskapligt granskadÖppen tillgång
A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
Kumar, J. Kiran; Aronsson, A. C.; Pilko, G. et al.
Forskningsartikel2015Vetenskapligt granskadÖppen tillgång
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
Jagarlamudi, Kiran Kumar; Hansson, Lars Olof; Eriksson, Staffan.
Forskningsartikel2015Vetenskapligt granskadÖppen tillgång
A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management : Dog TK1-ELISA
Jagarlamudi, Kiran Kumar; Moreau, Laura; Westberg, Sara et al.
Doktorsavhandling2015Öppen tillgång
Diagnostic implications of the molecular forms and levels of serum thymidine kinase 1 in different canine malignancies
Jagarlamudi, Kiran Kumar.
Forskningsartikel2014Vetenskapligt granskadÖppen tillgång
Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker
Jagarlamudi KK, Westberg S, Ronnberg H, Eriksson S.
Konferensabstrakt2014
The new TK 201 ELISA provides prognostic information in patients with breast cancer
Kumar, K. J.; Aronsson, A. C.; Pilko, G. et al.
Forskningsartikel2013Vetenskapligt granskad
High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: Implications for in vitro diagnostics
Jagarlamudi, Kiran Kumar; Sharif, Hanan; Westberg, Sara et al.
Forskningsartikel2012Vetenskapligt granskadÖppen tillgång
Quaternary Structures of Recombinant, Cellular and Serum Forms of Thymidine Kinase 1 from Dogs and Humans
Sharif, Hanan; Jagarlamudi, Kiran Kumar; Wang, Liya et al.
Konferensabstrakt2012Vetenskapligt granskad
The increase in serum thymidine kinase 1 subunit levels is more significant than the TK1-activities in samples from patients with solid tumors; implications for disease detection and monitoring efficiency
Jagarlamudi, K-K; Sharif, H.; von Euler, S. H. et al.